Skip to main content
Log in

Vedolizumab

Clostridium difficile infection: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Peverelle M, et al. Real-world outcomes of vedolizumab for inflammatory bowel disease post liver transplantation. Journal of Crohn's and Colitis 12 (Suppl. 1): S356-S357 abstr. P496, Feb 2018 [abstract] - Australia

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vedolizumab. Reactions Weekly 1697, 382 (2018). https://doi.org/10.1007/s40278-018-44938-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44938-9

Navigation